| Product NDC: | 0143-9708 |
| Proprietary Name: | Milrinone Lactate |
| Non Proprietary Name: | Milrinone Lactate |
| Active Ingredient(s): | 50 mg/50mL & nbsp; Milrinone Lactate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0143-9708 |
| Labeler Name: | West-ward Pharmaceutical Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077966 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101203 |
| Package NDC: | 0143-9708-10 |
| Package Description: | 10 VIAL in 1 BOX (0143-9708-10) > 50 mL in 1 VIAL (0143-9708-01) |
| NDC Code | 0143-9708-10 |
| Proprietary Name | Milrinone Lactate |
| Package Description | 10 VIAL in 1 BOX (0143-9708-10) > 50 mL in 1 VIAL (0143-9708-01) |
| Product NDC | 0143-9708 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Milrinone Lactate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20101203 |
| Marketing Category Name | ANDA |
| Labeler Name | West-ward Pharmaceutical Corp |
| Substance Name | MILRINONE LACTATE |
| Strength Number | 50 |
| Strength Unit | mg/50mL |
| Pharmaceutical Classes | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |